260 related articles for article (PubMed ID: 15509667)
1. Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.
Yoshizawa K; Walker NJ; Jokinen MP; Brix AE; Sells DM; Marsh T; Wyde ME; Orzech D; Haseman JK; Nyska A
Toxicol Sci; 2005 Jan; 83(1):64-77. PubMed ID: 15509667
[TBL] [Abstract][Full Text] [Related]
2. Reproductive lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin and dioxin-like compounds.
Yoshizawa K; Brix AE; Sells DM; Jokinen MP; Wyde M; Orzech DP; Kissling GE; Walker NJ; Nyska A
Toxicol Pathol; 2009 Dec; 37(7):921-37. PubMed ID: 19843953
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
4. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (559):1-174. PubMed ID: 21383778
[TBL] [Abstract][Full Text] [Related]
7. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
9. Thyroid follicular lesions induced by oral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds in female Harlan Sprague-Dawley rats.
Yoshizawa K; Walker NJ; Nyska A; Kissling GE; Jokinen MP; Brix AE; Sells DM; Wyde ME
Toxicol Pathol; 2010 Dec; 38(7):1037-50. PubMed ID: 20924081
[TBL] [Abstract][Full Text] [Related]
10. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
12. Olfactory epithelial metaplasia and hyperplasia in female Harlan Sprague-Dawley rats following chronic treatment with polychlorinated biphenyls.
Nyska A; Yoshizawa K; Jokinen MP; Brix AE; Sells DM; Wyde ME; Orzech DP; Kissling GE; Walker NJ
Toxicol Pathol; 2005; 33(3):371-7. PubMed ID: 15805076
[TBL] [Abstract][Full Text] [Related]
13. Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.
Nyska A; Jokinen MP; Brix AE; Sells DM; Wyde ME; Orzech D; Haseman JK; Flake G; Walker NJ
Environ Health Perspect; 2004 Jun; 112(8):903-9. PubMed ID: 15175180
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
[TBL] [Abstract][Full Text] [Related]
15. Increase in cardiovascular pathology in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3',4,4',5-pentachlorobiphenyl.
Jokinen MP; Walker NJ; Brix AE; Sells DM; Haseman JK; Nyska A
Cardiovasc Toxicol; 2003; 3(4):299-310. PubMed ID: 14734827
[TBL] [Abstract][Full Text] [Related]
16. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression.
Vezina CM; Walker NJ; Olson JR
Environ Health Perspect; 2004 Nov; 112(16):1636-44. PubMed ID: 15598615
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin-like compounds.
Walker NJ; Yoshizawa K; Miller RA; Brix AE; Sells DM; Jokinen MP; Wyde ME; Easterling M; Nyska A
Toxicol Pathol; 2007 Dec; 35(7):880-9. PubMed ID: 18098034
[TBL] [Abstract][Full Text] [Related]
18. A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF.
Yoshizawa K; Heatherly A; Malarkey DE; Walker NJ; Nyska A
Toxicol Pathol; 2007 Dec; 35(7):865-79. PubMed ID: 18098033
[TBL] [Abstract][Full Text] [Related]
19. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
20. The relative abilities of TCDD and its congeners to induce oxidative stress in the hepatic and brain tissues of rats after subchronic exposure.
Hassoun EA; Li F; Abushaban A; Stohs SJ
Toxicology; 2000 Apr; 145(2-3):103-13. PubMed ID: 10771135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
